Statistik Asas
| CIK | 1512922 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PetVivo Holdings, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan senarai kronologi lengkap bagi Pemfailan SEC, tidak termasuk pemfailan pemilikan yang kami sediakan di tempat lain.
| August 14, 2025 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. (Name |
|
| July 10, 2025 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”), dated the 10th day of November, 2021 (the “Effective Date”), is by and between PetVivo Holdings, Inc. a Nevada corporation (“Company”), and Robert J. Folkes, a resident of Minnesota (“Executive”). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chi |
|
| July 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40715 PetVivo Holdings, Inc. (Name of |
|
| July 10, 2025 |
Exhibit 10.3 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and Randall Meyer (the “Executive” and together with the Company, each a “Party,” and collectively the “Parties.”) RECITALS WHEREAS, the Parties enter |
|
| July 10, 2025 |
Exhibit 10.11 LEASE AGREEMENT TABLE OF CONTENTS ARTICLE 1 GRANTING CLAUSE 3 ARTICLE 2 ACCEPTANCE OF PREMISES AND TENANT IMPROVEMENT ALLOWANCE 4 ARTICLE 3 USE 5 ARTICLE 4 RENT 6 ARTICLE 5 SECURITY DEPOSIT 9 ARTICLE 6 LATE CHARGE AND INTEREST 9 ARTICLE 7 UTILITIES 10 ARTICLE 8 REPAIRS AND MAINTENANCE 10 ARTICLE 9 ALTERATIONS 12 ARTICLE 10 INSURANCE 13 ARTICLE 11 ASSIGNMENT AND SUBLETTING BY TENANT 1 |
|
| July 10, 2025 |
Exhibit 10.1 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and John Lai (the “Executive” and together with the Company, each a “Party,” and collectively the “Parties.”) RECITALS WHEREAS, the Parties entered in |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Year Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q ☐ Transition Report on For |
|
| June 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 24, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 24, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| June 24, 2025 |
Exhibit 3.1 PETVIVO HOLDINGS, INC. CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Chapter 78 of the Nevada Revised Statutes PetVivo Holdings, Inc., a Nevada corporation (the “Company”), hereby certify that the following resolution was duly adopted effective December 1, 2024, by the Board of Directors of the Company (the “Board”), acting pur |
|
| June 20, 2025 |
Exhibit 3.1 PETVIVO HOLDINGS, INC. CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Chapter 78 of the Nevada Revised Statutes PetVivo Holdings, Inc., a Nevada corporation (the “Company”), hereby certify that the following resolution was duly adopted effective December 1, 2024, by the Board of Directors of the Company (the “Board”), acting pur |
|
| June 20, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 20, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 20, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| June 16, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 16, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 16, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| June 16, 2025 |
Exhibit 3.1 PETVIVO HOLDINGS, INC. CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Chapter 78 of the Nevada Revised Statutes PetVivo Holdings, Inc., a Nevada corporation (the “Company”), hereby certify that the following resolution was duly adopted effective December 1, 2024, by the Board of Directors of the Company (the “Board”), acting pur |
|
| June 12, 2025 |
Exhibit 10.1 PROMISSORY NOTE $160,000.00 Edina, Minnesota June 10, 2025 FOR VALUE RECEIVED, the undersigned, PetVivo Holdings, Inc., a corporation incorporated in the state of Nevada (“Borrower”), hereby promises to pay to the order of , an individual having a principal address identified below (“Lender”), the principal sum of One Hundred Sixty Thousand Dollars ($160,000.00) (“Principal Sum” or “N |
|
| June 12, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 9, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 7, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| April 8, 2025 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 7, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 8, 2025 |
Exhibit 16.1 April 1, 2025 Rob Costantino Audit Committee Chair Petvivo Holdings, Inc. 5251 Edina Industrial Blvd. Edina, MN 55439 Dear Mr. Costantino: Effective April 1, 2025, we will cease providing audit services as your auditors. This decision was reached reluctantly and only after careful consideration, as we have made the strategic choice to exit the provision of audit services to publicly t |
|
| March 31, 2025 |
Exhibit 3.1 PETVIVO HOLDINGS, INC. CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Chapter 78 of the Nevada Revised Statutes PetVivo Holdings, Inc., a Nevada corporation (the “Company”), hereby certify that the following resolution was duly adopted effective December 1, 2024, by the Board of Directors of the Company (the “Board”), acting pur |
|
| March 31, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| March 31, 2025 |
Exhibit 3.1 PETVIVO HOLDINGS, INC. CERTIFICATE OF DESIGNATION OF RIGHTS AND PREFERENCES OF SERIES B CONVERTIBLE PREFERRED STOCK Pursuant to Chapter 78 of the Nevada Revised Statutes PetVivo Holdings, Inc., a Nevada corporation (the “Company”), hereby certify that the following resolution was duly adopted effective December 1, 2024, by the Board of Directors of the Company (the “Board”), acting pur |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 31, 2025 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Series B Convertible Preferred Stock Offering - $1.00 Per Share $5,000,000 March 26 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) share of PetVivo series B conve |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 26, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation |
|
| March 26, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 25, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 26, 2025 |
Exhibit 10.1 FIRST AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN PETVIVO HOLDING, INC. AND JOHN LAI THIS AMENDMENT (this “Amendment”) by and among PetVivo Holdings, Inc. (“PETVIVO” or the “Company”), and John Lai (“Employee”) is made and entered into as of the 25th day of March, 2025 and having an Effective Date of May 1, 2024. RECITALS WHEREAS, the Company and Employee entered into an Employment Agre |
|
| March 10, 2025 |
Exhibit 10.1 PROMISSORY NOTE $200,000.00 Edina, Minnesota , 2025 FOR VALUE RECEIVED, the undersigned, PetVivo Holdings, Inc., a corporation incorporated in the state of Nevada (“Borrower”), hereby promises to pay to the order of , an individual having a principal address identified below (“Lender”), the principal sum of Two Hundred Thousand Dollars ($200,000.00) (“Principal Sum” or “Note”) togethe |
|
| March 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 6, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| February 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 28, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 28, 2025 |
Amended and Restated By-laws of PetVivo Animal Health, Inc. Exhibit 3.2 |
|
| February 28, 2025 |
Certificate of Amendment of Amended and Restated Certificate of Incorporation Exhibit 3.1 |
|
| February 28, 2025 |
Press Release of Name Change to PetVivo Animal Health, Inc., dated February 27, 2025 Exhibit 99.1 |
|
| February 18, 2025 |
Exhibit 10.1 PROMISSORY NOTE $,000.00 Edina, Minnesota February 12, 2025 FOR VALUE RECEIVED, the undersigned, PetVivo Holdings, Inc., a corporation incorporated in the state of Nevada (“Borrower”), hereby promises to pay to the order of , an individual having a principal address identified below (“Lender”), the principal sum of Hundred Thousand Dollars ($,000.00) (“Principal Sum” or “Note”) togeth |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 14, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 18, 2025 |
Exhibit 99.1 PetVivo Signs Exclusive Sales and Marketing Agreement with VetStem for PrecisePRP® Canine and Equine Products MINNEAPOLIS, MN, Feb. 14, 2025 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (OTCQB: PETV; OTCPINK: PETVW), a leader in innovative veterinary medical solutions, has entered into an Exclusive License and Supply Agreement with VetStem, Inc. to commercialize VetStem’s innovative allo |
|
| February 18, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 14, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 14, 2025 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. ( |
|
| February 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 13, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 13, 2025 |
Form of Subscription Agreement EX-10.1 2 ex10-1.htm Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Common Stock Offering - $0.65 Per Share $500,000 January 2025 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up shares (collectively, the “Shares” and individually a “Share”), each Share consisting of one (1) restricted share of PetVivo common st |
|
| February 4, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 31, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 2, 2025 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| January 2, 2025 |
PetVivo Holdings, Inc. Investor Presentation dated January 2025 Exhibit 99.1 |
|
| December 26, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 26, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| December 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: Preliminary Information Statement - PR 14C Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement PetVivo Holdings, Inc |
|
| December 26, 2024 |
PetVivo Holdings, Inc. Investor Presentation dated December 2024 Exhibit 99.1 |
|
| November 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION STATEMENT Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement - PR 14C – Amendment 1 Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) Definitive Information Statement PetVivo |
|
| November 19, 2024 |
PETV / PetVivo Holdings, Inc. / A.L. Sarroff Fund, LLC - AMENDMENT NO. 6 TO SC13G Passive Investment SC 13G/A 1 sc13ga.htm AMENDMENT NO. 6 TO SC13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDED SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 6)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) November 19, 2024 (Date of Event which Requires Filing of this Statement) |
|
| November 14, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. |
|
| November 4, 2024 |
PETV / PetVivo Holdings, Inc. / NAZARENKO ALEX Passive Investment SC 13G 1 formsc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (OTCQB: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) October 10, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursu |
|
| October 10, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 8, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDED SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) October 1, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule p |
|
| October 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 1, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| September 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 26, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission |
|
| September 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 6, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| August 14, 2024 |
EXHIBIT 10.1 Effective as of May 1, 2024, PetVivo Holdings, Inc. (the “Company”) reduced the salary of John Lai, its Chief Executive Officer and President from $350,00 annually to $150,000 annually in connection with the Company’s cost reduction program. All other terms of the employment agreement effective as of November 10, 2021, as amended, between the Company and Mr. Lai remain the same. |
|
| August 14, 2024 |
EXHIBIT 10.2 Effective as of May 1, 2024, PetVivo Holdings, Inc. (the “Company”) reduced the salary of Randal Meyer, its Chief Operating Officer from $270,00 annually to $150,000 annually in connection with the Company’s cost reduction program. All other terms of the employment agreement effective as of November 10, 2021, as amended, between the Company and Mr. Meyer remain the same. |
|
| August 14, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. (Name |
|
| July 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 25, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| July 17, 2024 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Preferred Stock and Warrant Offering - $0.40 Per Unit $1,500,000 July , 2024 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up units (collectively, the “Units” and individually a “Unit”), each Unit consisting of one (1) share of PetVivo series A convertible preferred |
|
| July 17, 2024 |
Exhibit 4.1 Warrant No. PET- , 2024 [Form of] WARRANT To Purchase Thousand (,000) Shares of Common Stock of PETVIVO HOLDINGS, INC. , 2024 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STATES. THESE SECURITIE |
|
| July 17, 2024 |
Exhibit 3.1 |
|
| July 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 16, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| July 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40715 PetVivo Hol |
|
| June 28, 2024 |
Petvivo Holdings, Inc. Clawback Policy.*+ Exhibit 97 PETVIVO HOLDINGS, INC. CLAWBACK POLICY (Effective November 28, 2023) This PetVivo Holdings, Inc. Clawback Policy (this “Policy”) was approved effective as of November 28, 2023 (the “Effective Date”) by the Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of PetVivo Holdings, Inc. (the “Company”). This Policy is adopted pursuant to and intended to comply w |
|
| June 28, 2024 |
PetVivo Reports Reports Fiscal 2024 Results Exhibit 99.1 PetVivo Reports Reports Fiscal 2024 Results MINNEAPOLIS, MN, US, June 28, 2024 — PetVivo Holdings, Inc. (OTC: PETV, PETVW), a leading biomedical company delivering innovative therapeutic medical devices for equines and companion animals, reported results for the fiscal year ended March 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will h |
|
| June 28, 2024 |
Description of Registrant’s Securities* Exhibit 4.1 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the securities of PetVivo Holdings, Inc., a Nevada corporation (“PetVivo,” “we,” or “the Company”) which are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, which are (i) shares of the Company’s Com |
|
| June 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40715 PetVivo Holdings, Inc. (Exact n |
|
| June 28, 2024 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 28, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Amendment No. 4)* Under the Securities Exchange Act of 1934 PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) May 15, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) April 29, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant t |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 7, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 13, 2024 |
Exhibit 4.1 Warrant No. PET- , 2024 [Form of] WARRANT To Purchase Thousand ( ,000) Shares of Common Stock of PETVIVO HOLDINGS, INC. , 2024 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STATES. THESE SECURITI |
|
| May 13, 2024 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Common Stock and Warrant Offering - $0.70 Per Unit $2,200,000 April 9, 2024 PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up units (“Units” and individually “Unit”), each unit consisting of one (1) share of its common stock and one (1) common stock purchase warrant, |
|
| May 9, 2024 |
SC 13G/A 1 sc13g-amend.htm AMENDMENT NO. 2 TO SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) April 29, 2024 (Date of Event which Requires Filing of this Statement) |
|
| May 1, 2024 |
Conversion Agreement dated April 29, 2024 between the Company and the Noteholder Exhibit 10.1 SHORT-TERM PROMISSORY NOTE CONVERSION AGREEMENT THIS AGREEMENT, made and effective this 29th day of April, 2024, by and between PetVivo Holdings, Inc., a Nevada corporation (“PETVIVO”), and the following named Short-Term Promissory Note holder of PETVIVO: A. L. Sarroff Fund LLC, a limited liability company having a primary address of 43 Meadow Woods Road, Great Neck, NY 11020 (the “NO |
|
| May 1, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 29, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 26, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 15, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 19, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 15, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 16, 2024 |
Promissory Note dated April 10, 2024 between the Company and the Lender Exhibit 10.1 |
|
| April 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 10, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 9, 2024 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 5, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) February 9, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| March 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 8, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 14, 2024 |
Exhibit 99.1 Source: PetVivo Holdings, Inc. March 11, 2024 08:00 ET Garry Lowenthal Joins PetVivo Holdings, Inc. as the Chief Financial Officer MINNEAPOLIS, MN, US, March 11, 2024 (GLOBE NEWSWIRE) — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals |
|
| March 14, 2024 |
Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT dated the 8th day of March, 2024, is by and between PetVivo Holdings, Inc. a Nevada corporation (“Company”), and Garry Lowenthal, an individual having a primary residence identified in the signature page below (“Executive”). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the ca |
|
| March 11, 2024 |
Termination of a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 7, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 7, 2024 |
The date of this prospectus supplement is March 7, 2024 Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT NO. 1 (To Prospectus dated May 13, 2022 and the Prospectus Supplement dated August 23, 2023) This prospectus supplement (this “Supplement”) amends and supplements the prospectus supplement of PetVivo Holdings, Inc. (“we” or “us”) dated August 23, 2023 (the “Original Prospectus Supplement”). This Supplement should be |
|
| March 6, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 5, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 6, 2024 |
Exhibit 99.1 5251 Edina Industrial Blvd. Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: PetVivo Holdings, Inc. Commences Trading on Upstream Under PETV PetVivo Dual Lists on Upstream’s Global Securities Trading App MINNEAPOLIS, March 5, 2024 — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (“PetVivo”) an emerging biomedical device company focused on the commercialization of |
|
| February 12, 2024 |
Exhibit 99.1 PetVivo Reports Third Quarter of Fiscal 2024 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (February 12, 2024) – PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended December 31, 2023 (“thir |
|
| February 12, 2024 |
EXHIBIT 10.2 CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND REPLACED WITH “ [***]” BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT PETVIVO HOLDINGS, INC. TREATS AS PRIVATE OR CONFIDENTIAL. FIRST AMENDMENT TO DISTRIBUTION SERVICES AGREEMENT BETWEEN PETVIVO HOLDING, INC. AND MWI VETERINARY SUPPLY COMPANY THIS AMENDMENT (this “Amendment”) is made and entered into |
|
| February 12, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 12, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 12, 2024 |
Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND REPLACED WITH “ [***]” BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT PETVIVO HOLDINGS, INC. TREATS AS PRIVATE OR CONFIDENTIAL. DISTRIBUTION AGREEMENT THIS DISTRIBUTION AGREEMENT (this “Agreement”) is effective as of January 1, 2024 (the “Effective Date”) by and between PetVivo Holdings, Inc (“Vendor |
|
| February 12, 2024 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. ( |
|
| February 9, 2024 |
First Amendment to Promissory Note dated November 13, 2023 between the Company and the Lender Exhibit 10.2 FIRST AMENDMENT TO PROMISSORY NOTE BETWEEN PETVIVO HOLDING, INC. AND ALAN SARROFF THIS AMENDMENT (this “Amendment”) is made and entered into as of the 13th day of November, 2023 by and among PetVivo Holdings, Inc. (the “Borrower”), and Alan Sarroff (“Lender”). RECITALS WHEREAS, Lender and Borrower entered into a Promissory Note dated as of October 16, 2023 (“Note”); and WHEREAS, Lende |
|
| February 9, 2024 |
Promissory Note dated October 16, 2023 between the Company and the Lender EX-10.1 2 ex10-1.htm Exhibit 10.1 PROMISSORY NOTE $120,000.00 Edina, Minnesota October 16, 2023 FOR VALUE RECEIVED, the undersigned, PetVivo Holdings, Inc., a corporation incorporated in the state of Nevada (“Borrower”), hereby promises to pay to the order of Alan Sarroff an individual having a primary residence at the address identified below (“Lender”), the principal sum of One Hundred Twenty Th |
|
| February 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 16, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 7, 2024 |
Form of Subscription Agreement Exhibit 10.1 SUBSCRIPTION AGREEMENT AND INVESTMENT LETTER PRIVATE OFFERING PETVIVO HOLDING, INC. (PETV) Common Stock and Warrant Offering - $0.90 Per Unit PetVivo Holdings, Inc., a Nevada corporation (“PetVivo”) is hereby offering up units (“Units” and individually “Unit”), each unit consisting of one (1) share of its common stock and one (1) common stock purchase warrant, at $0.90 per unit pursua |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 6, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 2, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| February 7, 2024 |
Exhibit 4.1 Warrant No. PET- February 2, 2024 [Form of] WARRANT To Purchase Thousand (,000) Shares of Common Stock of PETVIVO HOLDINGS, INC. February 2, 2024 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STA |
|
| January 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 19, 2024 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 18, 2024 |
US7168174081 / PetVivo Holdings Inc / A.L. Sarroff Fund, LLC - AMENDMENT NO. 1 Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) December 6, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| December 22, 2023 |
Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 18, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| December 19, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 13, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| November 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 17, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| November 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 17, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| November 14, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. |
|
| November 14, 2023 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 14, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| November 14, 2023 |
Exhibit 99.1 PetVivo Reports Second Quarter of Fiscal 2024 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (November 14, 2023) – PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended September 30, 2023 (“se |
|
| October 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Definitive |
|
| October 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive |
|
| September 13, 2023 |
Exhibit 10.1 CONFIDENTIAL SETTLEMENT AGREEMENT AND MUTUAL RELEASE This Confidential Settlement Agreement and Mutual Release (“Agreement”) is entered into the last date signed below and is effective as of March 14, 2022 (the “Effective Date”) by and between PetVivo Holdings, Inc., a Nevada corporation, and its wholly-owned subsidiaries (collectively referred to herein as the “Company” or “PetVivo”) |
|
| September 13, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 8, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 2, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| August 24, 2023 |
Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT (To Prospectus dated May 13, 2022) Up to $2,500,000 Shares of Common Stock PetVivo Holdings, Inc. We have entered into an ATM Sales Agreement (the “Sales Agreement”) with ThinkEquity LLC (“ThinkEquity” or “Sales Agent”) relating to shares of our common stock, par value $0.001 per share, offered by this prospectus su |
|
| August 24, 2023 |
Exhibit 10.1 PETVIVO HOLDINGS, INC. Up to $2,500,000 Shares of Common Stock ATM Sales Agreement August 23, 2023 ThinkEquity LLC 17 State Street, 41st Floor New York, New York 10004 Ladies and Gentlemen: PetVivo Holdings, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with ThinkEquity LLC (the “Agent”), as follows: 1. Issuance and Sale of Shares. The Company a |
|
| August 24, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 23, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 21, 2023 |
SC 13G 1 sc13g.htm STATEMENT OF ACQUISITION OF BENEFICIAL OWNERSHIP UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* PetVivo Holdings, Inc. (Name of Issuer) Common Stock, (Nasdaq: PETV) (Title of Class of Securities) 716817408 (CUSIP Number) August 11, 2023 (Date of Event which Requires Filing of this S |
|
| August 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 15, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 11, 2023 |
Exhibit 4.1 WARRANT To Purchase Shares of Common Stock of PETVIVO HOLDINGS, INC. August 11, 2023 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFER |
|
| August 11, 2023 |
Form of Convertible Debenture Conversion Agreement dated August 11, 2023 Exhibit 10.1 CONVERTIBLE DEBENTURE CONVERSION AGREEMENT THIS CONVERTIBLE DEBENTURE CONVERSION AGREEMENT (this “Agreement”) is made and entered into as of the 11th day of August, 2023 (“Effective Date”) by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”), and the individual listed on the signature page hereto (the “Debenture Holder”). WHEREAS, the Debenture Holder holds a Co |
|
| August 11, 2023 |
Financial Statements and Exhibits, Entry into a Material Definitive Agreement UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 11, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 10, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 10, 2023 |
Exhibit 99.1 PetVivo Reports First Quarter of Fiscal 2024 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (August 10, 2023) – PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three months ended June 30, 2023 (“ |
|
| August 10, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. (Name |
|
| August 9, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 4, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| August 9, 2023 |
Form of Securities Purchase Agreement dated August 4, 2023 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is made as of August , 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”), and the purchasers identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”). RECITALS WHEREAS, subject to the terms a |
|
| August 9, 2023 |
Exhibit 4.1 WARRANT To Purchase Shares of Common Stock of PETVIVO HOLDINGS, INC. August , 2023 THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE OR CONVERSION OF THIS WARRANT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER THE SECURITIES LAWS OF ANY STATES OF THE UNITED STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERAB |
|
| August 7, 2023 |
1,333,333 Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT (To Prospectus dated May 13, 2022) 1,333,333 Shares of Common Stock We are offering up to 1,333,333 shares of our common stock, par value $0.001 per share, directly to certain accredited investors and qualified institutional investors at a price of $1.50 per share, pursuant to this prospectus supplement and the acco |
|
| July 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 27, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| July 31, 2023 |
Exhibit 10.1 Maturity Date: January 26, 2024 THE DEBENTURE REPRESENTED BY THIS CERTIFICATE AND THE COMMON STOCK UNDERLYING SUCH DEBENTURE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AND MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF (a) AN EFFECTIVE REGISTRATION STATEMENT FOR THE DEBENTURE AND/OR COMMON STOCK UNDER THE SECURITIES ACT OF 1933 OR (b) AN OPINION REASONABLY SATISFACTOR |
|
| July 31, 2023 |
Form of Debenture Purchase Agreement Exhibit 10.2 PETVIVO HOLDINGS, INC. DEBENTURE SUBSCRIPTION AGREEMENT This Debenture Subscription Agreement (this “Agreement”) is made as of the date of acceptance by PETVIVO HOLDINGS, Inc., a Nevada corporation (the “Company”) of the terms hereof, by and between the Company, and the undersigned (“Purchaser”). WHEREAS, Purchaser wishes to subscribe for and purchase a Convertible Debenture of the Co |
|
| July 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2023 petvivo holdings, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| July 21, 2023 |
PetVivo Holdings, Inc. Investor Presentation dated July 2023 Exhibit 99.1 |
|
| June 30, 2023 |
PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023 Exhibit 99.1 PETVIVO HOLDINGS, INC. ANNOUNCES RESCHEDULED EARNINGS CALL FOR THE YEAR ENDED MARCH 31, 2023 MINNEAPOLIS, MN, US, June 29, 2023, PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals, announced it has rescheduled its earnings conference call for the year ending Ma |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 29, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporatio |
|
| June 29, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”), dated the 10th day of November, 2021 (the “Effective Date”), is by and between PetVivo Holdings, Inc. a Nevada corporation (“Company”), and John Lai, a resident of Minnesota (“Executive”). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chief Execu |
|
| June 29, 2023 |
Exhibit 99.1 PetVivo Reports Fiscal 2023 Full Year Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (June 29, 2023) – PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for its fiscal year ended March 31, 2023 (“fiscal 2023”). Key |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 29, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40715 PetVivo Holdings, Inc. (Exact n |
|
| June 29, 2023 |
EXECUTIVE EMPLOYMENT AGREEMENT Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”), dated the 10th day of November, 2021 (the “Effective Date”), is by and between PetVivo Holdings, Inc. a Nevada corporation (“Company”), and Randall Meyer, a resident of Minnesota (“Executive”). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chief |
|
| June 29, 2023 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (“Agreement”), dated the 10th day of November, 2021 (the “Effective Date”), is by and between PetVivo Holdings, Inc. a Nevada corporation (“Company”), and Robert J. Folkes, a resident of Minnesota (“Executive”). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chi |
|
| June 29, 2023 |
Description of Registrant’s Securities * Exhibit 4.1 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following is a brief description of the securities of PetVivo Holdings, Inc., a Nevada corporation (“PetVivo,” “we,” or “the Company”) which are registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended, which are (i) shares of the Company’s Com |
|
| June 29, 2023 |
Exhibit 10.10 lease agreement TABLE OF CONTENTS ARTICLE 1 GRANTING CLAUSE 3 ARTICLE 2 ACCEPTANCE OF PREMISES AND TENANT IMPROVEMENT ALLOWANCE 3 ARTICLE 3 USE 4 ARTICLE 4 RENT 5 ARTICLE 5 SECURITY DEPOSIT 9 ARTICLE 6 LATE CHARGE AND INTEREST 9 ARTICLE 7 UTILITIES 9 ARTICLE 8 REPAIRS AND MAINTENANCE 10 ARTICLE 9 ALTERATIONS 12 ARTICLE 10 INSURANCE 12 ARTICLE 11 ASSIGNMENT AND SUBLETTING BY TENANT 13 |
|
| June 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 14, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| May 26, 2023 |
Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT (To Prospectus dated May 13, 2022) Up to $3,600,000 Up to 240,000 Units, Each Unit Consisting of One Share of 12% Cumulative Redeemable Perpetual Preferred Stock and Two Warrants Each Exercisable to Purchase One Share of Common Stock We are offering (this “Offering”) up to 240,000 Units directly to investors at an o |
|
| April 25, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 17, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporati |
|
| April 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 17, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| April 18, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is made as of April 17, 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”). RECITALS WHEREAS, subject to the terms a |
|
| April 18, 2023 |
Exhibit 10.2 FINDER’S FEE AGREEMENT THIS FINDER’S FEE AGREEMENT (“Agreement”) is made as of March 28, 2023 (the “Effective Date”), by and between, PetVivo Holdings, Inc., a Nevada corporation, with its principal headquarters located at 5251 Edina Industrial Blvd, Edina, MN 55439 (the “Company”), and Bancroft Capital, LLC (the “Finder”). WHEREAS, the Finder is registered with the Financial Institut |
|
| April 17, 2023 |
Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT NO. 2 (To Prospectus Supplement dated March 28, 2023 and accompanying Prospectus dated May 13, 2022) Up to $2,750,000 This prospectus supplement is being filed to update, amend and supplement certain information in the prospectus supplement, dated March 28, 2023 (the “Original Prospectus Supplement”), and the accomp |
|
| April 17, 2023 |
5251 Edina Industrial Blvd. Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com Exhibit 99.1 PETVIVO HOLDINGS, INC. 5251 Edina Industrial Blvd. Minneapolis, MN 55439 | (952) 405-6216 | www.petvivo.com PRESS RELEASE: Spencer Breithaupt Joins PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, April 14, 2023 — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical ther |
|
| April 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 14, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| March 30, 2023 |
1,000,000 Shares of Common Stock Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT (To Prospectus dated May 13, 2022) 1,000,000 Shares of Common Stock We are offering up to 1,000,000 shares of our common stock, par value $0.001 per share, directly to certain accredited investors and qualified institutional investors at a price of $2.75 per share, pursuant to this prospectus supplement and the acco |
|
| February 24, 2023 |
Exhibit 10.1 SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS SECOND AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) is effective as of February 24, 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and John Lai (the “Executive” and together with the Company, each a “Party,” and collectively the “Parties.”) RECITALS WHEREAS, the Parties entered |
|
| February 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 17, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 24, 2023 |
Exhibit 10.2 Participant Name: John Lai Number of Restricted Stock Units subject to Award: 60,600 Grant Date: February 24, 2023 PETVIVO HOLDINGS, INC. Restricted Stock Unit Award Agreement This agreement (this “Agreement”) evidences an award (the “Award”) of restricted stock units granted by PetVivo Holdings, Inc. (the “Company”) to John Lai (the “Participant”), pursuant to and subject to the term |
|
| February 9, 2023 |
Exhibit 99.1 PetVivo Reports Third Quarter of Fiscal 2023 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (February 9, 2023) – PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the third quarter of fiscal 2023. The |
|
| February 9, 2023 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. |
|
| February 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 9, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 5, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporat |
|
| January 19, 2023 |
Form of Amended and Restated Securities Purchase Agreement dated as of January 5, 2023 Exhibit 10.1 AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENT This Amended and Restated Securities Purchase Agreement (this “Agreement”) is made as of January 5, 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers” |
|
| January 13, 2023 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 10, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| January 13, 2023 |
PETVIVO HOLDINGS, INC. ANNOUCES PLAN FOR NEW MANUFACTURING FACILITY Exhibit 99.1 PETVIVO HOLDINGS, INC. ANNOUCES PLAN FOR NEW MANUFACTURING FACILITY MINNEAPOLIS, January 12, 2023 — PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (“PetVivo”) an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals today announced it has entered into a lease agreement for approximately 14,000 sq. ft. of |
|
| January 9, 2023 |
1,000,000 Shares of Common Stock 424B5 1 form424b5.htm Filed pursuant to Rule 424(b)(5) Registration No. 333-264700 PROSPECTUS SUPPLEMENT (To Prospectus dated May 13, 2022) 1,000,000 Shares of Common Stock We are offering 1,000,000 shares of our common stock, par value $0.001 per share, directly to certain accredited investors and qualified institutional investors at a price of $2.32 per share, pursuant to this prospectus supplem |
|
| January 9, 2023 |
Securities Purchase Agreement dated as of January 5, 2023 EX-10.1 3 ex10-1.htm Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is made as of January 5, 2023, by and between PetVivo Holdings, Inc., a Nevada corporation (the “Company”) and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and, collectively, the “Purchasers”). RECITALS WHEREAS, |
|
| January 9, 2023 |
EX-FILING FEES 2 ex107.htm EXHIBIT 107 The prospectus supplement to which this Exhibit is attached is a final prospectus for the related offering. The maximum aggregate offering price of that offering is $2,320,000 with the filing fee of $255.66. |
|
| January 9, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 January 5, 2023 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| November 10, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc |
|
| November 10, 2022 |
Exhibit 99.1 PetVivo Reports Second Quarter of Fiscal 2023 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (November 10, 2022) ? PetVivo Holdings, Inc. (?PetVivo? or the ?Company?) (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the second quarte |
|
| November 10, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 10, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| October 24, 2022 |
Exhibit 10.4 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the ?Company?) and John Dolan (the ?Executive? and together with the Company, each a ?Party,? and collectively the ?Parties.?) RECITALS WHEREAS, the Parties entered |
|
| October 24, 2022 |
Exhibit 10.3 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the ?Company?) and Randall Meyer (the ?Executive? and together with the Company, each a ?Party,? and collectively the ?Parties.?) RECITALS WHEREAS, the Parties enter |
|
| October 24, 2022 |
Exhibit 10.2 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the ?Company?) and Robert J. Folkes (the ?Executive? and together with the Company, each a ?Party,? and collectively the ?Parties.?) RECITALS WHEREAS, the Parties en |
|
| October 24, 2022 |
Exhibit 10.1 FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT THIS FIRST AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT (this ?Amendment?) is effective as of November 1, 2022, by and between PetVivo Holdings, Inc., a Nevada corporation (the ?Company?) and John Lai (the ?Executive? and together with the Company, each a ?Party,? and collectively the ?Parties.?) RECITALS WHEREAS, the Parties entered in |
|
| October 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 19, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| October 18, 2022 |
As filed with the Securities and Exchange Commission on October 18, 2022 As filed with the Securities and Exchange Commission on October 18, 2022 Registration No. |
|
| October 18, 2022 |
EXHIBIT 3.2 AMENDED AND RESTATED BYLAWS OF PETVIVO HOLDINGS, INC. 1.1 REGISTERED AGENT AND OFFICE. The registered agent of the Corporation (the ?Corporation?) shall be as set forth in the Corporation?s articles of incorporation, as may be amended and/or restated from time to time (the ?Articles of Incorporation?) and the registered office of the Corporation shall be the street office of that agent |
|
| October 18, 2022 |
EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) PetVivo Holdings, Inc. |
|
| October 17, 2022 |
Exhibit 10.1 Appendix A PETVIVO HOLDINGS, INC. AMENDED AND RESTATED 2020 EQUITY INCENTIVE PLAN Table of Contents 1. Purposes of the Plan: Prior Plan 1 2. Definitions. 1 3. Plan Administration. 6 4. Shares Available for Issuance. 8 5. Participation. 10 6. Options. 10 7. Stock Appreciation Rights. 11 8. Restricted Stock Awards, Restricted Stock Units and Deferred Stock Units. 12 9. Performance Award |
|
| October 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 October 14, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| August 26, 2022 |
DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| August 26, 2022 |
DEFA14A 1 formdefa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| August 11, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40715 PetVivo Holdings, Inc. (Ex |
|
| August 11, 2022 |
Exhibit 10.1 CERTAIN CONFIDENTIAL INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND REPLACED WITH “ [***]” BECAUSE IT IS NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT PETVIVO HOLDINGS, INC. TREATS AS PRIVATE OR CONFIDENTIAL. DISTRIBUTION SERVICES AGREEMENT This Distribution Services Agreement (“Agreement”) is made as of June 17, 2022 (“Effective Date”), by and between MWI Veterinary Supply Co., |
|
| August 11, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 11, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 11, 2022 |
Exhibit 99.1 PetVivo Reports First Quarter of Fiscal 2023 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (August 11, 2022) ? PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the first quarter of fiscal 2023. Highlights from |
|
| August 5, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 27, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporatio |
|
| August 5, 2022 |
Other Events, Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 2, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| August 5, 2022 |
Leslie Coolidge and Rob Costantino Join PetVivo Holdings, Inc. Board of Directors Exhibit 99.1 PRESS RELEASE: Leslie Coolidge and Rob Costantino Join PetVivo Holdings, Inc. Board of Directors MINNEAPOLIS, MN, US, August 1, 2022 ? PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the ?Company?) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for companion animals and animal athletes is pleased to announce that Rob Costantino |
|
| August 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 1, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 29, 2022 |
Exhibit 99.1 PetVivo to Discuss Financial Results for the Fiscal Year End ended March 31, 2022 and Business Update Conference call begins at 4:00 p.m. Central time today EDINA, MN (June 29, 2022) ? PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for it |
|
| June 29, 2022 |
Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 29, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 24, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 17, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| June 24, 2022 |
Exhibit 10.6 Participant Name: Number of Restricted Stock Units subject to Award: Grant Date: PETVIVO HOLDINGS, INC. 2020 Equity Incentive Plan Restricted Stock Unit Award Agreement This agreement (this ?Agreement?) evidences an award (the ?Award?) of restricted stock units granted by PetVivo Holdings, Inc. (the ?Company?) to the individual named above (the ?Participant?), pursuant to and subject |
|
| June 24, 2022 |
Exhibit 10.5 PETVIVO HOLDINGS, INC. Non-Qualified Stock Option Agreement Under the 2020 Equity Incentive Plan PetVivo Holdings, Inc. (the ?Company?), pursuant to its 2020 Equity Incentive Plan (the ?Plan?), hereby grants an Option to purchase shares of the Company?s common stock to you, the Participant named below. The terms and conditions of the Option Award are set forth in this Agreement, consi |
|
| June 24, 2022 |
Exhibit 21.1 LIST OF SUBSIDIARIES Name State of Incorporation Other Names PetVivo, Inc. Minnesota Gel-Del Technologies, Inc. Minnesota GelDel Cosmeta Corp. (a Gel-Del Technologies subsidiary) Minnesota |
|
| June 24, 2022 |
Articles of Incorporation, as amended* Exhibit 3.1 |
|
| June 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-55167 PetVivo Holdings, Inc. (Exact n |
|
| June 23, 2022 |
PETV / PetVivo Holdings Inc / Dolan John F. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* PETVIVO HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 716817200 (CUSIP Number) John Dolan c/o PetVivo Holdings, Inc. 5251 Edina Industrial Blvd. Edina, Minnesota 55439 (952) 405-6216 (Name, Address and Tele |
|
| June 23, 2022 |
PETV / PetVivo Holdings Inc / Meyer Randall A. Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. )* PETVIVO HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 716817200 (CUSIP Number) Randall Meyer c/o PetVivo Holdings, Inc. 5251 Edina Industrial Blvd. Edina, Minnesota 55439 (952) 405-6216 (Name, Address and Te |
|
| June 23, 2022 |
PETV / PetVivo Holdings Inc / Lai John Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* PETVIVO HOLDINGS, INC. (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 716817200 (CUSIP Number) John Lai c/o PetVivo Holdings, Inc. 5251 Edina Industrial Blvd. Edina, Minnesota 55439 (952) 405-6216 (Name, Address and Teleph |
|
| June 17, 2022 |
As filed with the Securities and Exchange Commission on June 17, 2022 S-8 1 forms-8.htm As filed with the Securities and Exchange Commission on June 17, 2022 Registration No. 333- United States SECURITIES AND EXCHANGE cOMMISSION Washington, D.C. 20549 fOrm S-8 registration statement under the securities act of 1933 PetVivo Holdings, Inc. (Exact name of registrant as specified in its charter) Nevada 99-0363559 (State or Other Jurisdiction of Incorporation or Organiza |
|
| June 17, 2022 |
EX-FILING FEES 5 ex107.htm EXHIBIT 107 Calculation of Filing Fee Table Form S-8 (Form Type) PetVivo Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Primary Offerin |
|
| June 17, 2022 |
Exhibit 3.1 |
|
| June 7, 2022 |
Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 June 2, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File N |
|
| May 12, 2022 |
CORRESP 1 filename1.htm PETVIVO HOLDINGS, INC. 5251 Edina Industrial Blvd. Edina, MN 55439 (952) 405-6216 May 12, 2022 Joshua Gorsky Division of Corporation Finance Office of Life Sciences 100 F Street, NE Washington, D.C., 20549 Re: PetVivo Holdings, Inc. Registration Statement on Form S-3 File No. 333-264700 Dear Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations und |
|
| May 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 May 4, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| May 5, 2022 |
S-3 1 forms-3.htm As filed with the Securities and Exchange Commission on May 5, 2022 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 PetVivo Holdings, Inc. (Exact Name of Registrant as Specified in Its Charter) Nevada 99-0363559 (State or Other Jurisdiction of Incorporation or Organizati |
|
| May 5, 2022 |
Exhibit 107 CALCULATION OF REGISTRATION FEE Title of Each Class of Securities To Be Registered(1) Amount To Be Registered(1) Proposed Maximum Offering Price Per Share(2) Proposed Maximum Aggregate Offering Price(2) Amount Of Registration Fee(3) Common Stock, par value $0. |
|
| March 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 March 4, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission File |
|
| February 11, 2022 |
PetVivo Holdings, Inc. 2,500,000 Units 424B3 1 form424b3.htm Prospectus Supplement No.2 (To Prospectus dated August 10, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-249452 PetVivo Holdings, Inc. 2,500,000 Units This prospectus supplement No. 2 amends and supplements the PetVivo Holdings, Inc. prospectus dated August 10, 2021, which was filed with the Securities and Exchange Commission on August 13, 2021 (the “Prospectus” |
|
| February 10, 2022 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55167 PetVivo Holdings Inc. (N |
|
| February 10, 2022 |
Results of Operations and Financial Condition, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 February 10, 2022 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| February 10, 2022 |
Exhibit 99.1 PetVivo Reports Third Quarter 2022 Financial Results Conference call begins at 4:00 p.m. Central time today EDINA, MN (February 10, 2022) ? PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, announces financial results for the three and nine months ended December 31, 2021. Highli |
|
| January 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive |
|
| January 18, 2022 |
DEFA14A 1 formdefa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule |
|
| January 3, 2022 |
Other Events, Shareholder Director Nominations UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 December 31, 2021 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 001-40715 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| December 7, 2021 |
PetVivo Holdings, Inc. 2,500,000 Units Prospectus Supplement No. 1 (To Prospectus dated August 10, 2021) Filed Pursuant to Rule 424(b)(3) Registration No. 333-249452 PetVivo Holdings, Inc. 2,500,000 Units This prospectus supplement No. 1 amends and supplements the PetVivo Holdings, Inc. prospectus dated August 10, 2021, which was filed with the Securities and Exchange Commission on August 13, 2021 (the ?Prospectus?), relating to the of |
|
| November 15, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 15, 2021 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| November 15, 2021 |
Exhibit 99.1 PetVivo Reports Second Quarter 2022 Financial Results Raised approximately 11.25 million in connection with Initial Public Offering Rebranded Kush? as Spryng? and commenced sales of Spryng? Conference call begins at 4:00 p.m. Central time today EDINA, MN (November 15, 2021) ? PetVivo Holdings, Inc. (Nasdaq: PETV), an emerging biomedical device company focused on the commercialization |
|
| November 15, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55167 PetVivo Holdings Inc. ( |
|
| November 10, 2021 |
Employment Agreement dated November 10, 2021 by and between PetVivo Holdings, Inc. and Randall Meyer Exhibit 10.3 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?), dated the 10th day of November, 2021 (the ?Effective Date?), is by and between PetVivo Holdings, Inc. a Nevada corporation (?Company?), and Randall Meyer, a resident of Minnesota (?Executive?). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chief |
|
| November 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 November 8, 2021 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission Fi |
|
| November 10, 2021 |
Employment Agreement dated November 10, 2021 by and between PetVivo Holdings, Inc. and John Lai Exhibit 10.1 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?), dated the 10th day of November, 2021 (the ?Effective Date?), is by and between PetVivo Holdings, Inc. a Nevada corporation (?Company?), and John Lai, a resident of Minnesota (?Executive?). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chief Execu |
|
| November 10, 2021 |
Exhibit 10.2 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?), dated the 10th day of November, 2021 (the ?Effective Date?), is by and between PetVivo Holdings, Inc. a Nevada corporation (?Company?), and Robert J. Folkes, a resident of Minnesota (?Executive?). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chi |
|
| November 10, 2021 |
Employment Agreement dated November 10, 2021 by and between PetVivo Holdings, Inc. and John Dolan Exhibit 10.4 EXECUTIVE EMPLOYMENT AGREEMENT THIS EXECUTIVE EMPLOYMENT AGREEMENT (?Agreement?), dated the 10th day of November, 2021 (the ?Effective Date?), is by and between PetVivo Holdings, Inc. a Nevada corporation (?Company?), and John Dolan, a resident of Minnesota (?Executive?). RECITALS A. Company wishes to hire and Executive wishes to be employed by the Company in the capacity of Chief Bus |
|
| September 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 September 9, 2021 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission F |
|
| September 14, 2021 |
Form of Restricted Stock Agreement Exhibit 10.1 PETVIVO HOLDINGS, INC. 2020 EQUITY INCENTIVE PLAN FORM OF RESTRICTED STOCK AGREEMENT This Agreement between PetVivo Holdings, Inc. (the ?Company?) and (?Participant?) shall be effective as of the date of grant. The Company and Participant agree as follows: 1.Grant of Restricted Stock. Participant is hereby granted Restricted Stock of the Company pursuant to the PetVivo Holdings, Inc. |
|
| August 18, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1) Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55167 PetVivo |
|
| August 16, 2021 |
PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing Exhibit 99.1 PetVivo Holdings Announces Pricing of Public Offering and Nasdaq Listing MINNEAPOLIS, MN, August 10, 2021 /PRNewswire/ ? PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (?PetVivo? or the ?Company?), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets, today announced the pricing of an underwritten pu |
|
| August 16, 2021 |
Exhibit 4.1 THE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE DATE (DEFIN |
|
| August 16, 2021 |
Other Events, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 August 13, 2021 Date of Report (Date of earliest event reported) PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 000-55167 99-0363559 (State or other jurisdiction of incorporation) (Commission Fil |
|
| August 16, 2021 |
PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing Exhibit 99.2 PetVivo Holdings Announces Closing of Public Offering and Nasdaq Listing MINNEAPOLIS, MN, August 13, 2021 Globe Newswire/ ? PetVivo Holdings, Inc. (Nasdaq: PETV, PETVW) (?PetVivo? or the ?Company?), an emerging biomedical device company focused on the licensing and commercialization of innovative medical devices and therapeutics for pets, today closed its previously announced underwri |
|
| August 16, 2021 |
Exhibit 99.3 Schedule 1 Premchand Beharry 3,625 William Bongiorno 3,000 Bruce & Nancy Inglis JTWROS 2,750 Robert Sagarino 2,000 William Baquet 10,462 Charles Giordano 1,363 Richard Adams 700 Phyllis Henderson 700 Kolinda Tomasic 200 Angela Kang 200 Ramnarain Jaigobind 39,625 Chirag Choudhary 8,500 Eric Lord 16,875 Kevin Mangan 11,646 Priyanka Mahajan 10,353 Nelson Baquet 2,000 Maria Robles 188 Cra |
|
| August 16, 2021 |
Exhibit 10.1 |
|
| August 16, 2021 |
U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark One ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55167 PetVivo Holdings Inc. (Name |
|
| August 16, 2021 |
Exhibit 1.1 |
|
| August 13, 2021 |
As filed with the Securities and Exchange Commission on August 13, 2021 As filed with the Securities and Exchange Commission on August 13, 2021 Registration Statement No. |
|
| August 13, 2021 |
Filed Pursuant to Rule 424(b)(4) Registration File No.: 333-249452 PROSPECTUS 2,500,000 Units PetVivo Holdings, Inc. This is a firm commitment offering of 2,500,000 units (the ?Units?) of PetVivo Holding, Inc., at an offering price of $4.50 per unit. Each Unit consists of one share of our common stock and one warrant to purchase one share of our common stock at an exercise price per share of $5.62 |
|
| August 5, 2021 |
8-A12B 1 form8a-12b.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 PETVIVO HOLDINGS, INC. (Exact name of registrant as specified in its charter) Nevada 99-0363559 (State or other jurisdiction of incorporation or organization) (I.R.S. Empl |
|
| August 5, 2021 |
PetVivo Holdings, Inc. PETVIVO HOLDINGS, INC. 5251 Edina Industrial Blvd. Edina, MN 55439 (952) 405-6216 August 5, 2021 Office of Life Sciences U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C., 20549 Re: PetVivo Holdings, Inc. (CIK No. 0001512922) Registration Statement on Form S-1 (File No. 333-249452) Dear Ladies and Gentlemen: Pursuant to Rule 461 of Regulation C (?Rule |
|
| August 5, 2021 |
August 5, 2021 VIA EDGAR Office of Life Sciences U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C., 20549 Re: PetVivo Holdings, Inc. Registration Statement on Form S-1, File No. 333-249452 Acceleration Request Requested Date: August 10, 2021 Requested Time: 4:30 p.m. Eastern Time (US) Ladies and Gentlemen: In connection with the above-referenced Registration Statement, and |
|
| July 13, 2021 |
Exhibit 4.2 WARRANT AGENT AGREEMENT WARRANT AGENT AGREEMENT (this ?Warrant Agreement?) dated as of , 2021 (the ?Issuance Date?) between PetVivo Holdings, Inc., a company incorporated under the laws of the State of Nevada (the ?Company?), and Equity Stock Transfer, LLC (the ?Warrant Agent?). WHEREAS, pursuant to the terms of that certain Underwriting Agreement (?Underwriting Agreement?), dated , 20 |
